Unique ID issued by UMIN | UMIN000040970 |
---|---|
Receipt number | R000045075 |
Scientific Title | Safety evaluation study of food containing plant extract |
Date of disclosure of the study information | 2020/07/01 |
Last modified on | 2022/04/13 18:45:27 |
Safety evaluation study of food containing plant extract
Safety evaluation study of food containing plant extract
Safety evaluation study of food containing plant extract
Safety evaluation study of food containing plant extract
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
The purpose of this study is to confirm the safety of taking the test food for 12 consecutive weeks
Safety
Exploratory
Pragmatic
Phase I
Side effects and adverse events
(Physical measurements, blood tests, urinalysis, vitals, doctor consultation)
RBMT(The Rivermead Behavioral Memory Test)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
No need to know
1
Prevention
Food |
Intake of the test food for 12 weeks (3 tablets / day)
40 | years-old | <= |
Not applicable |
Male and Female
1)Japanese male and female over 40 years old at the time of the informed consent.
2)Subjects who do not take medication or health food continuously.
3)Subjects whose Moca-J score is ranged from 18 to 28 before intake of the test food.
4) Subjects who have received a sufficient explanation of the purpose and contents of the examination, have the ability to make a self-judgment, voluntarity participate in the study after understanding the content enough and agree to participate in the study by signing the written informed consent.
5) Subjects who are able to visit the hospital regularly and are able to take the test food at home.
1) Subjects who have an allergy to the test food.
2) Subjecte whose GDS score is more than 10 before intake of the test food.
3)Subjects who has participated in other clinical studies (clinical trials) within 3 months before the start of the test or who is planning to participate in other clinical studies (clinical trials) during the study period.
4) Subjects who is current disease or a history of diabetes, liver disease (hepatitis), renal disease, serious diseases such as heart disease, thyroid disease, adrenal disease, or other metabolic diseases.
5)Subjects who are judged as unsuitable for the study by principal investigator or sub-investigator.
24
1st name | tazuo |
Middle name | |
Last name | okuno |
Kanazawa Medical University
Department of Geriatrics
920-0293
1-1 University, Uchinada town, Kahoku county, Ishikawa
076-286-2211
ma6-0219@kanazawa-med.ac.jp
1st name | Daisuke |
Middle name | |
Last name | Hama |
Kanazawa Medical University Hospital
Dementia Center
920-0293
1-1 University, Uchinada town, Kahoku county, Ishikawa
076-286-3511
hama-d@kanazawa-med.ac.jp
Kanazawa Medical University
Maruzen Pharmaceuticals CO., LTD
Profit organization
The ethical committees of the Kanazawa Medical University
1-1 University, Uchinada town, Kahoku county, Ishikawa
076-218-8346
tiken@kanazawa-med.ac.jp
NO
2020 | Year | 07 | Month | 01 | Day |
Unpublished
Completed
2020 | Year | 01 | Month | 30 | Day |
2020 | Year | 02 | Month | 12 | Day |
2020 | Year | 07 | Month | 01 | Day |
2022 | Year | 03 | Month | 31 | Day |
2020 | Year | 07 | Month | 01 | Day |
2022 | Year | 04 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045075
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |